These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1283187

  • 1. 24-hour blood pressure control after single daily doses of nivaldipine in patients with essential hypertension.
    Lossnitzer K, Huber HJ, Kuchlbauer R, Quitzdorff G.
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S35-42. PubMed ID: 1283187
    [Abstract] [Full Text] [Related]

  • 2. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S, Caglar N, Canberk A, Deger N, Demirtas M, Dortlemez H, Kiliccioglu B, Kozan O, Ovunc K, Turkoglu C.
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparisons of once-daily nilvadipine with enalapril and diuretic in patients with essential hypertension.
    Fritschka E.
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S62-8. PubMed ID: 1283192
    [Abstract] [Full Text] [Related]

  • 5. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM.
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [Abstract] [Full Text] [Related]

  • 6. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [Abstract] [Full Text] [Related]

  • 7. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G, Italian Study Group on Nilvadipine in Mild to Moderate Hypertension.
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J, Poirier L, Archambault F, Jewell D, Reed CV, Lacourcière Y.
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The long-term efficacy and safety profile of barnidipine.
    Smilde JG.
    Int J Clin Pract Suppl; 2000 Nov; (114):20-6. PubMed ID: 11221291
    [Abstract] [Full Text] [Related]

  • 17. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC, Calvo C, Ayala DE, López JE, Rodríguez M, Chayán L, Mojón A, Fontao MJ, Fernández JR.
    Chronobiol Int; 2007 Nov; 24(3):471-93. PubMed ID: 17612946
    [Abstract] [Full Text] [Related]

  • 18. Benidipine hydrochloride--a new calcium-channel blocker of the dihydropyridine type. Pharmacokinetics, pharmacodynamics, tolerance and dose finding in mild to moderate hypertension.
    Maier-Lenz H, Rode H, Lenau H, Thieme G, Wölke E, Kobayashi H, Kobayashi S, Oka T.
    Arzneimittelforschung; 1988 Nov; 38(11A):1757-63. PubMed ID: 3219156
    [Abstract] [Full Text] [Related]

  • 19. Nilvadipine in hypertension with renal dysfunction.
    Berger HH, Albert FW.
    J Cardiovasc Pharmacol; 1992 Nov; 20 Suppl 6():S73-9. PubMed ID: 1283194
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.